CIK 0001721484
- Emerging growth company
Longeveron Inc.
Sign in to watch- Ticker
- LGVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472174146
- Phone
- +1 305-302-7158
- Business address
- 1951 NW 7TH AVENUE, SUITE 520, MIAMI, FL, 33136
- Former names
- LONGEVERON LLC
- 4 Grant or award Director acquired 23,500 shares (grant or award)
- 4 Grant or award Director acquired 23,500 shares (grant or award)
- 4 Grant or award Director acquired 23,500 shares (grant or award)
- 4 Grant or award Director acquired 23,500 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 16,000 shares (grant or award)
- 4 Grant or award Director acquired 16,000 shares (grant or award)
- 4 Shares withheld for taxes Chief Financial Officer gave up 357 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 125 shares (to pay taxes)
- 4 Shares withheld for taxes General Counsel, Secretary gave up 325 shares (to pay taxes)
- 4 Grant or award Director acquired 16,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes Chief Financial Officer gave up 410 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 308 shares (to pay taxes)
- 4 Open-market buy Chief Scientific Officer bought 148,936 shares at $2.35 ($350,000)
- 4 Open-market buy Chief Executive Officer bought 10,638 shares at $2.35 ($24,999)
- 4 Open-market buy Director bought 138,298 shares at $2.35 ($325,000)
- 4 Shares withheld for taxes Chief Executive Officer gave up 32,866 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
Page 6 of 13 · 246 filings